Midday Gainers From November 17: Celldex Therapeutics, Amicus Therapeutics, Baker Hughes, Allergan
November 17, 2014 at 12:34 PM EST
Celldex Therapeutics, Inc.(NASDAQ: CLDX) +33% - Late Friday, the company announced interim results of its Phase 2 ReACT study ...